{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:43:54Z","timestamp":1771875834783,"version":"3.50.1"},"reference-count":79,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/s10227-001-0039-4","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T13:47:51Z","timestamp":1033912071000},"page":"128-150","source":"Crossref","is-referenced-by-count":3,"title":["A review of antibiotics in dermatology"],"prefix":"10.1177","volume":"6","author":[{"given":"Daniel A.","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody Vander","family":"Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"602000128_CR1","unstructured":"Kazung BG, Bertram J. Basic and Clinical Pharmacology. In: Norwalk, CT: Appleton & Lang, pp 43-50"},{"key":"602000128_CR2","unstructured":"Hirschmann JV. Overview of antibiotics. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick\u2019s Dermatology in General Medicine, 5th ed. New York: Mc Graw-Hill, pp 2829-2837"},{"key":"602000128_CR3","unstructured":"Kujath P et al. (2000) University of Lubeck, Germany; European Congress of Chemotherapy, Madrid, Spain, May 9, 2000"},{"issue":"19","key":"602000128_CR4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331(19): 1272\u20131285","journal-title":"N Engl J Med"},{"key":"602000128_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archderm.1984.01650400102024","volume":"120","author":"W Korkij","year":"1984","unstructured":"Korkij W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol 1984; 120:520\u2013524","journal-title":"Arch Dermatol"},{"key":"602000128_CR6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/clinids\/20.4.1010","volume":"20","author":"T Somer","year":"1995","unstructured":"Somer T, Finegold SM. Vasculitides associated with infections, immunizations, and antimicrobial drugs. Clin Infect Dis 1995; 20:1010\u20131036","journal-title":"Clin Infect Dis"},{"issue":"5","key":"602000128_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-4362.1991.tb03867.x","volume":"30","author":"V Ruocco","year":"1991","unstructured":"Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991; 30(5):307\u2013312","journal-title":"Int J Dermatol"},{"key":"602000128_CR8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","volume":"127","author":"JC Roujeau","year":"1991","unstructured":"Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127:1333\u20131338","journal-title":"Arch Dermatol"},{"issue":"5","key":"602000128_CR9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinte.1992.00400170020005","volume":"152","author":"RY Lin","year":"1991","unstructured":"Lin RY. A perspective on penicillin allergy. Arch Intern Med 1991; 152(5):930\u2013937","journal-title":"Arch Intern Med"},{"issue":"1","key":"602000128_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0031-3955(16)34327-9","volume":"30","author":"TH Sher","year":"1983","unstructured":"Sher TH. Penicillin hypersensitivity\u2014a review. Pediatr Clin North Am 1983; 30(1):161\u2013176","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"602000128_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0891-5520(05)70256-7","volume":"14","author":"LE Asbel","year":"2000","unstructured":"Asbel LE, Levison ME. Cephalosporins, carbapenems and monobactams. Infect Dis Clin North Am 2000; 14(2):435\u2013447","journal-title":"Infect Dis Clin North Am"},{"key":"602000128_CR12","unstructured":"Gilbert DN, Moellering RC, Sande MA (1999) The Sanford Guide to Antimicrobial Therapy, pp 35\u201339"},{"issue":"8596","key":"602000128_CR13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","volume":"1","author":"RJ Dattwyler","year":"1998","unstructured":"Dattwyler RJ, Halper JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis\u2014randomized comparison of ceftriaxone and penicillin. Lancet 1998; 1(8596):1191\u20131194","journal-title":"Lancet"},{"issue":"2","key":"602000128_CR14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7326\/0003-4819-107-2-204","volume":"107","author":"A Saxton","year":"1987","unstructured":"Saxton A, Beal GN, Rohr AS, et al. Immediate hypersensitivity reactions to beta-lactamantibiotics. Ann Intern Med 1987; 107(2): 204\u2013215","journal-title":"Ann Intern Med"},{"key":"602000128_CR15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/infdis\/158.2.474","volume":"158","author":"R Platt","year":"1988","unstructured":"Platt R, Dreis MW, Kennedy DL, et al. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. J Infect Dis 1988; 158:474\u2013477","journal-title":"J Infect Dis"},{"key":"602000128_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","volume":"137","author":"H Bachelez","year":"2001","unstructured":"Bachelez H, Senet P, Cadranel J, et al. The use of tetracycline for the treatment of sarcoidosis. Arch Dermatol 2001; 137:69\u201373","journal-title":"Arch Dermatol"},{"key":"602000128_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1040-0486(96)80004-4","volume":"8","author":"GF Webster","year":"1996","unstructured":"Webster GF. Acne. Curr Probl Dermatol 1996; 8:237\u2013241","journal-title":"Curr Probl Dermatol"},{"key":"602000128_CR18","unstructured":"Del Rosso J (2000) Meeting highlights, Acne and rosacea, 24th Annual Hawaii Dermatology Seminar, p 3 (Published by an unrestricted educational grant from Galderma)"},{"issue":"2","key":"602000128_CR19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0891-5520(05)70257-9","volume":"14","author":"JM Zuckerman","year":"2000","unstructured":"Zuckerman JM. The newer macrolides, azithromycin and clarithromycin. Infect Dis Clin North Am 2000; 14(2):449\u2013462","journal-title":"Infect Dis Clin North Am"},{"issue":"9","key":"602000128_CR20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/106002809202600912","volume":"26","author":"MG Sturgill","year":"1992","unstructured":"Sturgill MG, Rapp RP. Clarithromycin: Review of a new macrolide antibiotic with improved microbiologic spectum and favorable pharmaco kinetic and adverse effect profiles. Ann Pharmacother 1992; 26(9):1099\u20131108","journal-title":"Ann Pharmacother"},{"issue":"1","key":"602000128_CR21","first-page":"31","volume":"160","author":"MS Kanatani","year":"1994","unstructured":"Kanatani MS, Guglielmo BJ. The new macrolides: azithromycin and clarithromycin. West J Med 1994; 160(1):31\u201337","journal-title":"West J Med"},{"key":"602000128_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0190-9622(00)90132-4","volume":"42","author":"PK Sharma","year":"2000","unstructured":"Sharma PK, Yadav TP, Gautam RK, et al. Erythromycin in pityriasis rosea: A double blind, placebo-controlled clinical trial. J Am Acad Dermatol 2000; 42:241\u2013244","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"602000128_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF01780661","volume":"24","author":"F Strle","year":"1996","unstructured":"Strle F, Maraspin V, Lotric-Furlan S, et al. Azithromycin and doxycycline for the treatment of Borreliaculture-positive erythema migrans. Infection 1996; 24(1):64\u201368","journal-title":"Infection"},{"issue":"2","key":"602000128_CR24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/AAC.40.2.468","volume":"40","author":"RJ Dattwylen","year":"1996","unstructured":"Dattwylen RJ, Grunwaldt E, Luft BJ. Clarithromycin in the treatment of early Lyme disease: a pilot study. Antimicrob Agents Chemother 1996; 40(2):468\u2013469","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"602000128_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/25.suppl_A.115","volume":"25","author":"A Lassus","year":"1990","unstructured":"Lassus A. Comparative studies of azithromycin in skin and soft tissue infections and sexually transmitted infections byNeisseria andChlamydia species. J Antimicrob Chemother 1990; 25(Suppl A): 115\u2013121","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"602000128_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","volume":"15","author":"DJ Hardy","year":"1992","unstructured":"Hardy DJ, Guay DRP, Jones RN. Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological and clinical overview. Diagn Microbiol Infect Dis 1992; 15(1):39\u201353","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3A","key":"602000128_CR27","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0002-9343(91)90400-R","volume":"91","author":"SB Mallory","year":"1991","unstructured":"Mallory SB. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. Am J Med 1991; 91(3A):36S-39S","journal-title":"Am J Med"},{"issue":"2","key":"602000128_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-199403000-00010","volume":"21","author":"HH Handsfield","year":"1994","unstructured":"Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhea. Sex Transm Dis 1994; 21(2): 107\u2013111","journal-title":"Sex Transm Dis"},{"key":"602000128_CR29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","volume":"5","author":"GT Lesher","year":"1962","unstructured":"Lesher GT, Froelich EJ, Gruett JH, et al. 1,8-naphthyridine derivatives: a new class of chemotherapy agents. J Med Pharm Chem 1962; 5:1063\u20131067","journal-title":"J Med Pharm Chem"},{"issue":"2","key":"602000128_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/AAC.33.2.131","volume":"33","author":"DT Chu","year":"1989","unstructured":"Chu DT, Fernandes PB. Structure-activity relationship of thefluoroquinolones. Antimicrob Agents Chemother 1989; 33(2): 131\u2013135","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"602000128_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","volume":"33","author":"JM Domagala","year":"1994","unstructured":"Domagala JM. Structure-activity and structure-side effect relationships of the quinolone antibacterials. J Antimicrob Chemother 1994; 33(4):685\u2013706","journal-title":"J Antimicrob Chemother"},{"key":"602000128_CR32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0025-6196(11)64003-2","volume":"74","author":"RC Walker","year":"1999","unstructured":"Walker RC. The fluoroquinolones. Mayo Clin Proc 1999; 74: 1030\u20131034","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"602000128_CR33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0891-5520(05)70260-9","volume":"14","author":"JA O\u2019Donnell","year":"2000","unstructured":"O\u2019Donnell JA, Gelone SP. Fluoroquinolones. Infect Dis Clin North Am 2000; 14(2):489\u2013513","journal-title":"Infect Dis Clin North Am"},{"key":"602000128_CR34","first-page":"41","volume":"10","author":"KA Rodvold","year":"1999","unstructured":"Rodvold KA. Clinical safety profile of newer fluoroquinolones. Infect Med 1999; 10(Supp):41\u201343","journal-title":"Infect Med"},{"issue":"18","key":"602000128_CR35","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1001\/jama.1988.03410180090035","volume":"260","author":"MS Klempner","year":"1988","unstructured":"Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose clindamycin therapy. JAMA 1988; 260(18):2682\u20132685","journal-title":"JAMA"},{"issue":"11","key":"602000128_CR36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0025-6196(12)61126-4","volume":"67","author":"MJ Zalla","year":"1992","unstructured":"Zalla MJ, Su WP, Fransway AF. Dermatologic manifestations of human immunodeficiency virus infection. Mayo Clin Proc 1992; 67(11):1089\u20131108","journal-title":"Mayo Clin Proc"},{"key":"602000128_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0041-3879(87)90034-1","volume":"68","author":"SD Purohit","year":"1987","unstructured":"Purohit SD, Supta ML, Gupia PR. Dietary constituents and rifampicin absorption. Tuberculosis 1987; 68:151","journal-title":"Tuberculosis"},{"key":"602000128_CR38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2230.1991.tb00317.x","volume":"16","author":"V Ramesh","year":"1991","unstructured":"Ramesh V, Misra RS, Saxena V, et al. A comparative of efficacy of drug regimens in skin tuberculosis. Clin Exp Dermatol 1991; 16:106\u2013109","journal-title":"Clin Exp Dermatol"},{"key":"602000128_CR39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/archderm.1995.01690180021003","volume":"131","author":"DM Hoss","year":"1995","unstructured":"Hoss DM, Feder HM. Addition of rifampicin to conventional therapy for recurrent furunculosis. Arch Dermatol 1995; 131:647\u2013648","journal-title":"Arch Dermatol"},{"key":"602000128_CR40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1017\/S002221510011388X","volume":"10","author":"AM Gamea","year":"1990","unstructured":"Gamea AM, El-Tatawi FA. The effect of rifampicin on rhinoscleroma. J Laryngol Otol 1990; 10:772\u2013777","journal-title":"J Laryngol Otol"},{"issue":"3S","key":"602000128_CR41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/clinids\/5.Supplement_3.S440","volume":"5","author":"J Grosset","year":"1983","unstructured":"Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis 1983; 5(3S):440\u2013446","journal-title":"Rev Infect Dis"},{"issue":"1","key":"602000128_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12543487","volume":"70","author":"NB Esterly","year":"1978","unstructured":"Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocytechemotaxis. J Invest Dermatol 1978; 70(1):51\u201355","journal-title":"J Invest Dermatol"},{"key":"602000128_CR43","unstructured":"Metronidazole (topical). In: Drug Information for the Health Care Professionals (USP DI). Rockville, MD: U.S. Pharmacopeial Convention, 1997, pp 2028\u20132029"},{"key":"602000128_CR44","unstructured":"Wolf JE (2000) Meeting highlights, Acne and rosacea, 24th Annual Hawaii Dermatology Seminar, p 1 (Published by an unrestricted educational grant from Galderma)"},{"key":"602000128_CR45","unstructured":"Hirschmann JV. Overview of antibiotics. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick\u2019s Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, pp 2306-2318"},{"key":"602000128_CR46","unstructured":"Hirschmann JV. Overview of antibiotics. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick\u2019s Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, pp 2790-2794"},{"key":"602000128_CR47","first-page":"435","volume":"16","author":"C Ford","year":"1999","unstructured":"Ford C, Hamel J, Stapert D. Oxazolidinones: A new class of antimicrobials. Infect Med 1999; 16:435","journal-title":"Infect Med"},{"key":"602000128_CR48","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/jm980274l","volume":"41","author":"JA Tucker","year":"1998","unstructured":"Tucker JA, Allwine DA, Grega KC, et al. Piperazinyl oxazolidinones antibacterial agents containing apyridine, diazine or triazene hetero aromatic ring. J Med Chem. 1998; 41:3727\u20133735","journal-title":"J Med Chem."},{"issue":"3","key":"602000128_CR49","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/j.1875-9114.1998.tb03109.x","volume":"18","author":"LD Dresser","year":"1998","unstructured":"Dresser LD, Rybak MJ. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 1998; 18(3):456\u2013462","journal-title":"Pharmacotherapy"},{"issue":"3","key":"602000128_CR50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.42.3.721","volume":"42","author":"MJ Rybak","year":"1998","unstructured":"Rybak MJ, Capelletty DM, Moldovan T, et al. Comparative in vitro activities and postantibiotic effects ofthe oxazolidinones compounds eperezolid (PNU-100592) and linezolid(PNU-100766) versus vancomycin againstStaphylococcus aureus, coagulase negative staphylococci,Enterococcus faecalis, andEnterococcus faecium. Antimicrob Agents Chemother 1998; 42(3):721\u2013724","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"602000128_CR51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","volume":"40","author":"GE Zurenko","year":"1996","unstructured":"Zurenko GE, Yagi BH, Schaadt RD, et al. In vitro activities of PNU 100592 and PNU 100766, noveloxazolidinones antibacterial agents. Antimicrob Agents Chemother 1996; 40(4):839\u2013845","journal-title":"Antimicrob Agents Chemother"},{"key":"602000128_CR52","unstructured":"Anonymous. Linezolid (Zyvox). Med Lett 2000; 14(1079):45-46"},{"issue":"2","key":"602000128_CR53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5520(05)70258-0","volume":"14","author":"TS Lundstrom","year":"2000","unstructured":"Lundstrom TS, Sobel JD. Antibiotics for gram-positive bacterial infections. Infect Dis Clin North Am 2000; 14(2):463\u2013474","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"602000128_CR54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/106002809502901013","volume":"29","author":"C Chant","year":"1995","unstructured":"Chant C, Rybak MJ. Quinupristin\/dalfopristin (RP 59500): a new streptograminantibiotic. Ann Pharmacother 1995; 29(10):1022\u20131027","journal-title":"Ann Pharmacother"},{"issue":"2","key":"602000128_CR55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000239542","volume":"43","author":"SM Qadri","year":"1997","unstructured":"Qadri SM, Ueno Y, Abu Mostafa FM, et al. In vitro activity of quinupristin\/dalfopristin, RP 59500, against gram positive clinical isolates. Chemotherapy 1997; 43(2):94\u201399","journal-title":"Chemotherapy"},{"issue":"2","key":"602000128_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0891-5520(05)70250-6","volume":"14","author":"ET Kaye","year":"2000","unstructured":"Kaye ET. Topical antibacterial agents. Infect Dis Clin North Am 2000; 14(2):321\u2013340","journal-title":"Infect Dis Clin North Am"},{"key":"602000128_CR57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0733-8635(05)70418-6","volume":"15","author":"DM Thiboutot","year":"1997","unstructured":"Thiboutot DM. Acne: An overview of clinical research findings. Dermatol Clin 1997; 15:97\u2013109","journal-title":"Dermatol Clin"},{"key":"602000128_CR58","unstructured":"Bonner MW, Benson PM, James WD. Topical antibiotics in dermatology. In: Freedberg IM, Eisen AZ, Wolff K, et al. eds. Fitzpatrick\u2019s Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, pp 2829-2837"},{"key":"602000128_CR59","first-page":"23","volume":"10","author":"SF Bradley","year":"1993","unstructured":"Bradley SF. Effectiveness of mupirocin in the control of methicillin-resistantStaphylococcus aureus. Infect Med 1993; 10:23\u201328","journal-title":"Infect Med"},{"issue":"7","key":"602000128_CR60","first-page":"25","volume":"31","author":"LG Winston","year":"2000","unstructured":"Winston LG. Rifampin as antibiotic adjunct works well for recurrentboils. Skin Allergy News 2000; 31(7):25","journal-title":"Skin Allergy News"},{"key":"602000128_CR61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0733-8635(18)30296-1","volume":"11","author":"RE Williams","year":"1993","unstructured":"Williams RE, Mackie RM. The staphylococci. Importance of their control in the management of skin disease. Dermatol Clin 1993; 11:201\u2013206","journal-title":"Dermatol Clin"},{"key":"602000128_CR62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.1996.03540120050033","volume":"276","author":"OP Smack","year":"1996","unstructured":"Smack OP. Infections and allergy incidence in ambulatory surgery patientsusing white petrolatum versus bacitracin ointment. JAMA 1996; 276:972\u2013975","journal-title":"JAMA"},{"key":"602000128_CR63","unstructured":"Kapusnik-Uner JE. Tetracycline, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Hardman JG, et al, ed. Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill, pp 1123-1147"},{"issue":"4","key":"602000128_CR64","first-page":"227","volume":"36","author":"H Lindemayr","year":"1985","unstructured":"Lindemayr H, Drobil M. Eczema of the lower leg and contact allergy. Hautarzt 1985; 36(4):227\u2013231","journal-title":"Hautarzt"},{"key":"602000128_CR65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0536.1979.tb04806.x","volume":"5","author":"JE Fraki","year":"1985","unstructured":"Fraki JE, Peltonen L, Hopsu-Havu VK. Allergy to various components of topical preparations in stasisdermatitis and leg ulcer. Contact Dermatitis 1985; 5:97\u2013100","journal-title":"Contact Dermatitis"},{"key":"602000128_CR66","doi-asserted-by":"crossref","unstructured":"Klein JO. Otitis externa, otitis media, and mastoiditis. In: Mandell GL, Douglas RGL, Bennett JE eds. Principles and practice of infectious disease. New York: Churchill Livingstone, pp 505","DOI":"10.1016\/B978-0-443-06839-3.00057-6"},{"key":"602000128_CR67","unstructured":"Chambers HF, Sande MA. The aminoglycosides. In: Hardman JG, et al, ed. Goodman and Gilman\u2019s The Pharmacological Basis ofTherapeutics, 9th ed. New York: McGraw-Hill, pp 1123-1147"},{"key":"602000128_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1524-4725.1988.tb03359.x","volume":"14","author":"JM Scherbenske","year":"1998","unstructured":"Scherbenske JM, Winton GB, James WD. AcutePseudomonas infection of the external ear (malignant external otitis). J Dermatol Surg Oncol 1998; 14:165\u2013169","journal-title":"J Dermatol Surg Oncol"},{"key":"602000128_CR69","unstructured":"Teva Pharmaceutical Industries, Ltd. Package insert for Leshcutan (paromomycin sulfate, 15%, and methylbenzethonium chloride, 12%, ointment), Petah-Tikva, Israel"},{"key":"602000128_CR70","unstructured":"Lancini G. Antibiotics, A Multidisciplinary Approach. New York, Chapter 5: Plenum, pp 70-78"},{"key":"602000128_CR71","doi-asserted-by":"crossref","unstructured":"Edwards DI. Biosynthesis of antimicrobial drugs. In: Antimicrobial Drug Action. Baltimore, MD: University Park Press, pp 31-32","DOI":"10.1007\/978-1-349-16360-1_3"},{"key":"602000128_CR72","unstructured":"Chloramphenicol (topical). In: Drug Information for Health Care Professionals (USP DI). Rockville, MD: U.S. Pharmacopeial Convention, 1997, p 795"},{"key":"602000128_CR73","first-page":"3044","volume-title":"Physicians Desk Reference","author":"Roberts Pharmaceutical Corp.","year":"1997","unstructured":"Roberts Pharmaceutical Corp. (1997) Package insert for Furacin (nitrofurazone cream). In: Physicians Desk Reference, 51st ed. Montvale, NJ: Medical Economics, p 3044","edition":"51st ed."},{"key":"602000128_CR74","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1524-4725.1993.tb00417.x","volume":"19","author":"CD Brown","year":"1993","unstructured":"Brown CD, Zitelelli JA. A review of topical agents for wounds and methods of wounding. Guidelines for wound management. J Dermatol Surg Oncol 1993; 19:732\u2013737","journal-title":"J Dermatol Surg Oncol"},{"key":"602000128_CR75","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ptj\/75.6.526","volume":"75","author":"RS Ward","year":"1995","unstructured":"Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther 1995; 75:526\u2013538","journal-title":"Phys Ther"},{"issue":"18","key":"602000128_CR76","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1001\/jama.1988.03410180090035","volume":"260","author":"MS Klempner","year":"1988","unstructured":"Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose clindamycin therapy. JAMA 1988; 260(18):2682\u20132685","journal-title":"JAMA"},{"issue":"2","key":"602000128_CR77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/0003-4819-87-2-145","volume":"87","author":"HW Meislin","year":"1977","unstructured":"Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses: anaerobic and aerobic bacteriology andoutpatient management. Ann Intern Med 1977; 87(2):145\u2013149","journal-title":"Ann Intern Med"},{"issue":"4","key":"602000128_CR78","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bjs.1800640410","volume":"64","author":"J Macfie","year":"1977","unstructured":"Macfie J, Harvey J. The treatment of acute superficial abscesses: A prospective clinical trial. Br J Surg 1977; 64(4):264\u2013266","journal-title":"Br J Surg"},{"issue":"2","key":"602000128_CR79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0190-9622(95)90119-1","volume":"32","author":"AF Haas","year":"1995","unstructured":"Haas AF, Grekin RC. Antibiotic prophylaxis in dermatologic surgery. J Am Acad Dermatol 1995; 32(2 Part 1):155\u2013176","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1007\/s10227-001-0039-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T08:32:53Z","timestamp":1704529973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10227-001-0039-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["602000128"],"URL":"https:\/\/doi.org\/10.1007\/s10227-001-0039-4","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}